Tissue MicroArrays make possible the screening of hundreds of different tumors samples for the expression of a specific protein. Automatic features extraction procedures lead to a series of covariates corresponding to the averaged stained scores. In this article, we model the random geometry of tissue microarray cores thanks to voronoi tesselations. This formalism enables the computation of indices of spatial correlation of stained scores using both classical and novel approaches. The potential of these spatial statistics to correctly discriminate between diseased and non-diseased cases is evaluated through the analysis of a Tissue MicroArray containing samples of breast carcinoma data. The results points out a significatif improvement in the breast cancer prognosis.
Introduction
Tissue Micro-Arrays (TMAs) consist of high-throughput tissue-based tools that allow for the immunohistological analysis of large sample of tumor tissues (Kononen et al., 1998; Nocito et al., 2001) . TMAs enable the screening of hundreds of different tumors samples for the expression of a specific protein. They are utilized in in situ gene marker validation and discovery in cancer research projects thanks to their ability to rapidly evaluate the role of normal and abnormal genes and gene products from numerous tissues at once, and ultimately correlate genotypes with phenotypes. A typical example of a tissue array application is in searching for oncogenes amplifications in vast tumor tissue panels, encompassing differing stages and grades of disease.
Many automated treatments of TMAs are available, allowing measurements of fluorescence intensity, probe colocalization and other measures of protein expression. Although efficient software tools for counting cells and objects and estimating morphometric parameters exist, solutions for the statistical analysis of staining results are still lacking. A major difficulty is that TMAs core image information cannot be summarized easily and the relationships between genetic expression and tissue structure are still poorly understood.
In providing supervised classifiers that can assist pathologists in the prognosis of a disease, a crucial question is to know which covariates and indices provide the most information. In this paper, we evaluate the potential of spatial statistical quantities within the mathematical formalism of marked point processes (Stoyan et al., 1995) to correctly discriminate between diseased and non-diseased cases. Our approach to the statistical description of TMAs cores assumes pre-analyzed images where cell parameters have been segmented. Given these data, two types of statistical indices can be computed using the Voronoi tesselation associated with the stained cells. The first indices correspond to the classical spatial correlation indices of Moran (1950) and Geary (1954) (see also Møller, 1999) . The second indices are modified versions which attempt to account for the correlation of levels of expression in the highly expressed genes. This note is organized as follows. In section 2, we give a short account on the TMAs technology, and the existing automatic treatements of such data. In section 3, we describe statistical summaries of the tissues based on random geometry concepts. In section 4, the approach is illustrated by the analysis of a TMA containing samples of breast carcinoma data and tests based on the spatial statistics are assessed from this dataset.
Tissue Microarrays

Overview
TMAs are a method of re-locating tissue from conventional histologic paraffin blocks in order to be able to see tissues from multiple patients or blocks on the same slide. Hundreds of tiny cylindrical tissue cores (typically 0.6 mm diameter) are densely and precisely arrayed into a single histologic paraffin block. The block may be divided into serial 4 to 8 µm thick sections, which we refer to as tissue array slides. Typically, cores contain small histologic sections from unique tissues or tumors. These tissue array slides serve as targets for immunohistochemical staining reactions.
Several biomarkers can be embedded in TMAs. For example, the cell proliferation biomarker Ki-67, has been shown to be significantly associated with survival in prostate cancer (Bettencourt et al., 1996) , nuclear phospho-beta-catenin in colorectal cancer is associated with a better prognosis (Chung et al., 2001) , maspin is associated with breast cancer (Mass et al., 2001) and has a reverse correlation with mutant p53 (Zhang et al., 2002) , estrogen receptor and progesterone are utilized as well (Gehrig et al., 2000) , etc.
Each tissue array slide yields information about protein staining pattern, distribution, intensity, background and target tissue. In many cases, each spot on a tissue microarray is scored by a skilled pathologist and recorded manually. High-resolution digital images are automatically assembled into montages and usually saved as a TIFF format. Platforms that help organizing tissue microarrays datasets and provide elementary analysis 
Data description
A clinical study was designed to identify a set of proteins for which over-expression has diagnostic significance in breast cancer and can be assessed by immunohistochemical assays and quantitative bright field microscopy for routine diagnostic of breast cancer. The study was based upon a cohort of 132 patients including good and bad outcome patients. Good outcome are those that after five years are disease free, bad outcome is defined as recurrence or death within five years. The subset used in the article consists of 31 patients data taken from this clinical study.
TMAs were made of 60 cores each, organized following a grid with 6 columns and 10 rows called TMA key. Good and bad outcome patients were represented twice. Additional cores from normal breast tissue, liver and tonsil tissues were used as staining controls and as helpers in the placement of the cores. For the purpose of this methodological study the marker investigated was a 32-kilodalton dopamine and cyclic adenosine 3',5'monophosate-regulated phosphoprotein named DARPP-32. A recent study has showed that both DARPP-32 and t-DARPP mRNAs were frequently over-expressed in carcinomas of the breast, prostate, colon and stomach compared with normal tissue samples (Beckler et al., 2003) .
The immunohistochemical assay was optimized for staining in a series of experiments varying the antibody concentration and the antigen retrieval methods (data not reported).
The staining was optimized to have as low as possible staining in the good outcome and still a high staining in the bad outcome patients. Every TMA was processed with both a counterstain (Hematoxylin) and an immunochemical assay including polyclonal antibodies targeting the DARPP-32 protein revealed by DAB (brown). At the time of the study, these polyclonal antibodies had not yet been sorted and purified and therefore, the biological meaning of the staining intensity must be considered as preliminary data.
TMAs were scanned at 20x by the Tripath Imaging, Inc. proprietary slide scanning systems. Cores images were processed with Tripath Imaging, Inc. proprietary imaging system, using chromogen separation techniques to best separate marker contribution (DAB) from counterstain intensity (Hematoxylin). Each core was automatically segmented to obtain the position of every cell and finally extract features at cell and core level. These features were exported to a file used for further analysis. The approach presented here provides a simple mathematical representation of a TMA core based on random tesselation. It starts from a subset of cell locations (a list of two dimensional coordinates) and reconstructs a statistical model of the tissues from which a number of tests can be performed. Tissues are reconstructed using the Voronoi tesselation.
Modeling tissues with tesselations is a rather classical idea in biology and biometrics (Honda, 1983 ). More specifically, let us recall a definition of the Voronoi tesselation.
Consider a finite subset of locations or points in the plane. For each location p, the Voronoi cell V (p) is the set of all points that are closer to p than to all other locations in the subset.
The novelty of the approach presented here resides in the fact that stained scores are attached to the idealized Voronoi cells. Doing so, tissues can be viewed as well-studied abstract objects called marked point processes (Besag, 1975; Stoyan et al., 1995) . The paradigm presented here is that the marked point process should contain a model of interactions between cells and markers that can be measured using the geometric information of the tesselation.
Local correlation indices
A challenge for TMAs analysis is to pick a staining score (guided by prior biological knowledge) and find an index that could represent information at the level of the entire tissue. Thus our first concern is to define biomarker expression indices in relation with the spatial conformation of the tissues. Here the theory of marked point process comes to play. Let X i denote any score value associated with the cell i. 
where c(B) is defined by
j ∼ i means that i and j are neighbors, X is the mean value of X and σ 2 (B) the unbiased variance of X in B. Similarly, the Geary's index is
where
Both indices are closely related to the notion of spatial autocorrelation of scores. In Moran tests in order to detect the spatial correlation of specific morphologically changed structures that are known to be precursors of colon cancer development.
New indices
Moran's and Geary's indices may sometimes miss useful spatial information within a TMA core. For example, consider the two cores represented in Figure 1 The thresholded indices are defined as follows
with n(B θ ) the number of cells in B θ , M θ the average score over the neighbors of cells belonging to B θ :
and σ θ (B) the square root of The ability of a test to discriminate diseased cases from normal cases can be evaluated using Receiver Operating Characteristic (ROC) curve analyses (see Zweig et al., 1993) .
Regarding thresholds dependent methods such as ρ θ , the threshold was chosen so as to optimize the classification performances, i.e., the parameter associated with the maximal sensiticity and specificity.
Linear or nonlinear discriminant analysis, flexible or logistic regression are utilized as well. In order to apply such analyses, there is a need to pool multiple spot measurements across each case (patient). Since TMAs case data contain pooled estimates of spot biomarker staining scores across each case, the simplest pooling methods are to form the mean, median, standard deviation of the spot measurements (standard covariates).
These standard covariates do not account for the structure of the tissues and its random geometry. Discriminant analysis is aimed at evaluating the impact of the inclusion of global 
Results
A dataset corresponding to 31 cases (patients) TMAs cores fixed on a single slide has been utilized (section 2). The stained scores extracted from digital processing were rescaled and took values between 0 and 255. The scores considered were the cell (Cell.OD), the nucleus (Nucleus.OD) and cytoplasm (Cyto.OD) average optical densities of the biomarker measured locally. Among all available scores, these scores were chosen as the most representative for this specific dataset.
The discriminant power of tests were evaluated thanks to the measures of sensitivity (probability for a test result to be positive when the disease is present, ie true positive rate) and specificity (probability for a test result to be negative when the disease is not present, ie true negative rate). Recall that the data set contains 25 outcomes of disease (carcinoma recurrence) and 6 outcomes of non disease.
First, linear discriminant analysis and logistic regression were performed using a pool of core measurements. The pool contained six measures corresponding to the mean and standard deviation of the three scores Cell.OD, Nucleus.OD and Cyto.OD computed for each case.
Logistic regression was performed using R feedforward neural networks library nnet.
The number of hidden units in feedforward neural networks were determined using the jacknife method of cross-validation. The results are displayed in Table 1 . These results indicate low sensitivity and high specificity. The poor performances may be due to the fact that the three first covariates (means of OD) are strongly correlated (cor > 0.95). 
Discussion
Scientific progress in the understanding of tissues, their function, disease and biodynamics critically depend on the precision and quality of information available. Tissue specimens have been the primary source for medical diagnosis since the origin of microscopy. Despite fundamental progress in this area, the prevailing method for analyzing tissues today remains visual inspection, and relevant quantification of TMAs core images is still missing.
Many morphological parameters may be used in the grading of malignancy of cancerous tissue. For example, the shape of the cells in the tissue is an important feature. As well, the spatial conformation of cells in which genes may be over-or under-expressed seems critical (Bissell et al., 1999) . At present these parameters are usually estimated subjectively by the pathologists or described by simple ratios. Idealized mathematical models of tissues can provide further understanding of tissue contents and improve the accuracy of discrimination between samples or experimental groups. The crucial issues addressed in this study were the following: Are standard covariates such as mean and variance of stained scores able to provide discrimination between diseased and non-diseased cases? Is finer level analysis necessary? Do the thresholded indices ρ θ provide additional insights on the disease prognosis?
The resuts presented in section 4 proved that including specific tissue structure parameters such as Moran and Geary or thresholded indices led to increased classification performances. Nevertheless, these results also raised a series of issues. A first issue concerns the biomarker DARPP-32 itself. The strong correlation of standard covariates computed at the levels of cells, nuclei and cytoplasm indicates that DARPP-32 has no preferential attachment to one of these biological entities, and further experimental evidences are obviously necessary to assess the potential of DARPP-32 as a therapeutical target.
A second issue concerns the choice of a threshold θ or equivalently the choice of a subset B θ for use in the computation. In our analysis, the threshold was optimized in order to led to the best classification performances. The resulting parameter was found to be close to the median score. However, choosing a subset B θ of the form B theta = {i ∈ B , X i > θ} may not always be an optimal strategy. Consider for instance a biomarker which has different expressions in cytoplasm and nucleus according to the pathologic state of the tissue. In this situation, B θ could be taken as the subset of cells with significant differential expression. Because the distribution of covariates (eg, Nucleus.OD and Cyto.OD) is hardly Gaussian, additional normalization steps would be necessary in order to eliminate biases which may come from spurious sources. 
